MycoMedica Life Sciences Secures Funding

MycoMedica Life Sciences has secured $60 million in funding to fuel fungi based drug development for prevention and treatment of psychiatric and neurological disorders.

“We believe the Stamets Stack has the potential to unlock new medicines that offer transformative solutions for patients struggling with some of the most debilitating conditions,” said James Joaquin, Co-Founder & Managing Director at Obvious Ventures. “Paul and his team are an exceptional group of scientists, researchers and clinicians on a mission to make a difference, and we are excited and honored to join them on this world positive journey.”